Myc is a family of regulator genes and proto-oncogenes that code for transcription factors. These transcription factors play a crucial role in cell cycle progression, apoptosis, and cellular transformation. The Myc family includes c-Myc, N-Myc, and L-Myc, with c-Myc being the most studied due to its significant role in various cancers.
The Myc protein functions as a transcription factor that regulates the expression of numerous genes involved in cell growth and proliferation. It contains a basic helix-loop-helix leucine zipper (bHLH-ZIP) motif, which is essential for DNA binding and dimerization with other proteins such as Max. The Myc/Max complex binds to E-box sequences in the promoter regions of target genes, activating their transcription.
Polyclonal antibodies are produced by immunizing animals with an antigen, in this case, a synthetic peptide corresponding to amino-terminal residues of the Myc protein. The immune system of the animal generates a diverse array of antibodies that recognize multiple epitopes on the antigen. These antibodies are then harvested and purified for use in various research applications.
The production of Myc polyclonal antibodies involves several steps:
Myc polyclonal antibodies are widely used in various research applications, including:
The Myc protein is implicated in numerous cellular processes, and its dysregulation is associated with various cancers, including Burkitt lymphoma, leukemia, and other hematopoietic tumors. Understanding the role of Myc in these diseases is crucial for developing targeted therapies. Polyclonal antibodies against Myc provide researchers with valuable tools to study the protein’s function, regulation, and involvement in cancer.